Medicine Man Technologies, Inc.
SHWZ
$0.02
$0.01100.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 8.24% | 8.26% | -4.18% | 25.67% | 51.30% |
| Total Other Revenue | -98.92% | -2.40% | -96.12% | 173.93% | 101.34% |
| Total Revenue | 7.91% | 8.23% | -4.27% | 25.88% | 51.41% |
| Cost of Revenue | 96.93% | 22.18% | -6.55% | -18.58% | 28.21% |
| Gross Profit | -67.61% | -4.62% | -2.53% | 110.58% | 78.87% |
| SG&A Expenses | 32.45% | 10.15% | 21.34% | 10.52% | 90.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.75% | 17.92% | 6.22% | -6.06% | 51.27% |
| Operating Income | -362.25% | -19.72% | -45.14% | 217.94% | 52.27% |
| Income Before Tax | -4.94% | -30.85% | -103.83% | 125.11% | -255.64% |
| Income Tax Expenses | 23.51% | -2.71% | 16.72% | 270.05% | 51.72% |
| Earnings from Continuing Operations | -7.41% | -117.83% | -119.53% | 106.52% | -313.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.41% | -117.83% | -119.53% | 106.52% | -313.09% |
| EBIT | -362.25% | -19.72% | -45.14% | 217.94% | 52.27% |
| EBITDA | -217.53% | -22.86% | -19.71% | 624.58% | 77.57% |
| EPS Basic | 16.75% | -4,380.00% | -122.69% | 99.16% | -531.11% |
| Normalized Basic EPS | -50.82% | -59.54% | -103.11% | 121.06% | -157.25% |
| EPS Diluted | 18.28% | -14,300.00% | -162.50% | 89.74% | -1,639.68% |
| Normalized Diluted EPS | -50.82% | -28.78% | -108.43% | 111.57% | -401.98% |
| Average Basic Shares Outstanding | 27.14% | 70.21% | 23.10% | 19.20% | 26.27% |
| Average Diluted Shares Outstanding | 27.14% | -3.55% | -54.65% | 116.92% | -76.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
